PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 63 filers reported holding PROTAGONIST THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $7,724,000 | +53.1% | 750,632 | 0.0% | 26.59% | +31.4% |
| Q2 2018 | $5,044,000 | -40.2% | 750,632 | -23.6% | 20.23% | -4.5% |
| Q1 2018 | $8,438,000 | -58.7% | 982,270 | 0.0% | 21.20% | +0.9% |
| Q4 2017 | $20,431,000 | +17.7% | 982,270 | 0.0% | 21.00% | -58.5% |
| Q3 2017 | $17,357,000 | +56.2% | 982,270 | 0.0% | 50.60% | +31.4% |
| Q2 2017 | $11,109,000 | -11.7% | 982,270 | 0.0% | 38.52% | +14.7% |
| Q1 2017 | $12,583,000 | -41.8% | 982,270 | -0.1% | 33.57% | +80.2% |
| Q4 2016 | $21,628,000 | – | 983,570 | – | 18.63% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $20,647,000 | 6.08% |
| Bain Capital Life Sciences Investors, LLC | 2,260,572 | $19,057,000 | 2.28% |
| Kynam Capital Management, LP | 519,212 | $4,377,000 | 0.92% |
| RTW INVESTMENTS, LP | 4,176,837 | $35,211,000 | 0.81% |
| Tri Locum Partners LP | 199,500 | $1,682,000 | 0.46% |
| Birchview Capital, LP | 38,000 | $320,000 | 0.22% |
| Gratus Capital, LLC | 206,113 | $1,738,000 | 0.18% |
| FARALLON CAPITAL MANAGEMENT LLC | 3,651,887 | $30,785,000 | 0.17% |
| PDT Partners, LLC | 126,038 | $1,063,000 | 0.16% |
| FOX RUN MANAGEMENT, L.L.C. | 40,683 | $343,000 | 0.13% |